JFG
Jefferies Financial Group Portfolio holdings
AUM
$6.06B
This Quarter Return
+0.98%
1 Year Return
+9.37%
3 Year Return
+16.02%
5 Year Return
+51.04%
10 Year Return
+258.41%
AUM
$5.09B
AUM Growth
+$5.09B
(+2.8%)
Cap. Flow
+$257M
Cap. Flow
% of AUM
5.06%
Top 10 Holdings %
Top 10 Hldgs %
29.56%
Holding
1,608
New
306
Increased
296
Reduced
272
Closed
450
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$157M |
| 2 |
Golar LNG
GLNG
|
$94.9M |
| 3 |
Geron
GERN
|
$84.1M |
| 4 |
Boston Scientific
BSX
|
$49.9M |
| 5 |
AbbVie
ABBV
|
$37.1M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$70.5M |
| 2 |
argenx
ARGX
|
$58.1M |
| 3 |
Delta Air Lines
DAL
|
$53M |
| 4 |
Moderna
MRNA
|
$45.7M |
| 5 |
JPMorgan Chase
JPM
|
$44.5M |
Sector Composition
| 1 | Healthcare | 20.58% |
| 2 | Technology | 8.7% |
| 3 | Energy | 8.39% |
| 4 | Industrials | 7.09% |
| 5 | Consumer Discretionary | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR S&P 500 ETF Trust
SPY
$658B
| $591M | 6.28% | 1,086,225 +287,967 | +36% | +$157M |
|
|
2
Golar LNG
GLNG
$4.48B
| $154M | 1.63% | 4,900,000 +3,027,798 | +162% | +$94.9M |
|
3
iShares Russell 2000 ETF
IWM
$67B
| $140M | 1.48% | 688,867 +118,374 | +21% | +$24M |
|
4
Invesco QQQ Trust
QQQ
$364B
| $122M | 1.3% | 255,602 -50,714 | -17% | -$24.3M |
|
5
Visa
V
$683B
| $112M | 1.19% | 427,407 -37,887 | -8% | -$9.94M |
|
6
Hillman Solutions
HLMN
$1.95B
| $87.3M | 0.93% | 9,866,866 +11,790 | +0.1% | +$104K |
|
|
7
Geron
GERN
$893M
| $84.9M | 0.9% | 20,030,000 +19,846,609 | +10,822% | +$84.1M |
|
8
Apple
AAPL
$3.45T
| $73.3M | 0.78% | 348,064 +94,925 | +37% | +$20M |
|
9
Protagonist Therapeutics
PTGX
$3.67B
| $70.7M | 0.75% | 2,040,561 +860,000 | +73% | +$29.8M |
|
10
Vanguard S&P 500 ETF
VOO
$726B
| $68.4M | 0.73% | 136,853 -37,720 | -22% | -$18.9M |
|
|
11
Boston Scientific
BSX
$156B
| $66.3M | 0.7% | 860,380 +647,731 | +305% | +$49.9M |
|
12
Cedar Fair
FUN
$2.3B
| $51.8M | 0.55% | 953,859 +215,945 | +29% | +$11.7M |
|
|
13
AbbVie
ABBV
$372B
| $48M | 0.51% | 279,721 +216,167 | +340% | +$37.1M |
|
14
Keros Therapeutics
KROS
$618M
| $41.1M | 0.44% | 899,077 +265,406 | +42% | +$12.1M |
|
15
Antero Resources
AR
$9.86B
| $37.3M | 0.4% | 1,144,271 +107,844 | +10% | +$3.52M |
|
16
EQT Corp
EQT
$32.4B
| $36.1M | 0.38% | 976,530 +395,655 | +68% | +$14.6M |
|
|
LGF.A
17
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $35.1M | 0.37% | 3,725,000 | – | – |
|
18
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.5B
| $34.9M | 0.37% | 326,014 -130,690 | -29% | -$14M |
|
19
Danaher
DHR
$147B
| $34.3M | 0.36% | 137,424 +110,340 | +407% | +$27.6M |
|
20
NVIDIA
NVDA
$4.24T
| $34.1M | 0.36% | 276,544 +203,023 | +276% | +$25.1M |
|
21
Pfizer
PFE
$141B
| $33.9M | 0.36% | 1,211,861 +746,856 | +161% | +$20.9M |
|
22
Walmart
WMT
$774B
| $32.3M | 0.34% | 477,644 +327,347 | +218% | +$22.2M |
|
23
Industrial Select Sector SPDR Fund
XLI
$23.3B
| $32.2M | 0.34% | 264,394 +60,017 | +29% | +$7.31M |
|
24
Alphabet (Google) Class A
GOOGL
$2.57T
| $31.7M | 0.34% | 174,126 +107,106 | +160% | +$19.5M |
|
25
ResMed
RMD
$40.2B
| $31.1M | 0.33% | 160,913 +146,613 | +1,025% | +$28.4M |
|